NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.
Patients undergoing total hip replacement surgery have a 400 percent increase potential of developing a hemorrhagic or ischemic stroke within the first weeks after their operation. Information provided in the journal Stroke, by the American Heart Association, indicates that the risk of stroke was significant within the first two weeks, which dropped off only 6 to 12 weeks later. The study indicated that it took one year for the potential risk of a stroke to be comparable to individuals not undergoing hip implant surgery.
The information was accumulated in the Netherlands from approximately 66,000 patients who had undergone total hip replacement surgery. The study evaluated their potential risk of a stroke based on individuals not having the procedure. The data indicated an increased potential of an ischemic stroke within the first six weeks postoperative, and an increased risk of developing a hemorrhagic stroke up to 12 weeks.